Influenza virus lung infection protects from respiratory syncytial virus-induced immunopathology.
about
Cross-reactivity between HLA-A2-restricted FLU-M1:58-66 and HIV p17 GAG:77-85 epitopes in HIV-infected and uninfected individualsVirus-induced secondary bacterial infection: a concise reviewCross-reactivity between hepatitis C virus and Influenza A virus determinant-specific cytotoxic T cells.RSV-Induced H3K4 Demethylase KDM5B Leads to Regulation of Dendritic Cell-Derived Innate Cytokines and Exacerbates Pathogenesis In VivoRespiratory infections: do we ever recover?Sustained desensitization to bacterial Toll-like receptor ligands after resolution of respiratory influenza infection.Interval Between Infections and Viral Hierarchy Are Determinants of Viral Interference Following Influenza Virus Infection in a Ferret Model.Differential role of gamma interferon in inhibiting pulmonary eosinophilia and exacerbating systemic disease in fusion protein-immunized mice undergoing challenge infection with respiratory syncytial virusFunctional group/guild modelling of inter-specific pathogen interactions: a potential tool for predicting the consequences of co-infection.Heterologous immunity between virusesHeterologous immunity: immunopathology, autoimmunity and protection during viral infections.Gastrointestinal helminths may affect host susceptibility to anthrax through seasonal immune trade-offs.Effects of respiratory Mycoplasma pneumoniae infection on allergen-induced bronchial hyperresponsiveness and lung inflammation in mice.Prior exposure to live Mycobacterium bovis BCG decreases Cryptococcus neoformans-induced lung eosinophilia in a gamma interferon-dependent mannerSuperinfection between influenza and RSV alternating patterns in San Luis Potosí State, México.Human cytomegalovirus infant infection adversely affects growth and development in maternally HIV-exposed and unexposed infants in Zambia.The periarterial space in the lung: its important role in lung edema, transplantation, and microbial or allergic inflammation.Interaction between unrelated viruses during in vivo co-infection to limit pathology and immunityPrivate aspects of heterologous immunity.Respiratory syncytial virus infection provokes airway remodelling in allergen-exposed mice in absence of prior allergen sensitization.Virus-like particle-induced protection against MRSA pneumonia is dependent on IL-13 and enhancement of phagocyte function.Virally delivered cytokines alter the immune response to future lung infectionsAge at first viral infection determines the pattern of T cell-mediated disease during reinfection in adulthoodRole of Baicalin in Anti-Influenza Virus A as a Potent Inducer of IFN-Gamma.Memory of mice and men: CD8+ T-cell cross-reactivity and heterologous immunity.A virus-like particle vaccine platform elicits heightened and hastened local lung mucosal antibody production after a single dose.Recombinant influenza virus carrying the respiratory syncytial virus (RSV) F85-93 CTL epitope reduces RSV replication in mice.Club cells surviving influenza A virus infection induce temporary nonspecific antiviral immunity.The immunopathogenesis of chronic obstructive pulmonary disease: insights from recent research.The impact of successive infections on the lung microenvironment.Influenza A virus among the hospitalized young children with acute respiratory infection. Is influenza A co infected with respiratory syncytial virus?MHV68 latency modulates the host immune response to influenza A virus.The two faces of heterologous immunity: protection or immunopathology.CD11c⁺ cells primed with unrelated antigens facilitate an accelerated immune response to influenza virus in mice.On the extinction probability in models of within-host infection: the role of latency and immunity.Amelioration of influenza-induced pathology in mice by coinfection with Trichinella spiralis.Induction of Antiviral Immune Response through Recognition of the Repeating Subunit Pattern of Viral Capsids Is Toll-Like Receptor 2 Dependent.Ménage à trois of bacterial and viral pulmonary pathogens delivers coup de grace to the lung.Non-specific Effect of Vaccines: Immediate Protection against Respiratory Syncytial Virus Infection by a Live Attenuated Influenza Vaccine.Influenza interaction with cocirculating pathogens and its impact on surveillance, pathogenesis, and epidemic profile: A key role for mathematical modelling.
P2860
Q24802424-028AB6F8-B224-4521-AF7E-EBB3FEAC12BDQ26783333-E4BA8CEC-0149-4D4D-9EB3-DA45B0AF3B3BQ27469883-F9783925-CEC4-4974-BD0E-6B1D389D8A1CQ28548423-94C043D6-87C6-421F-A2EE-7CBF50F55E9FQ30366426-3C3CB961-5DC4-471E-B4CE-2D177B68F60AQ30367425-25539215-883C-4B99-88D1-8E35F1E2F655Q30374400-6F4EAFF4-14AD-484C-A436-2B998F2D2C0EQ30441455-70624FBC-0FC4-4531-8CEF-6EE637F666B3Q33334278-4391726E-FCFF-4F80-910E-EC4102EABD9BQ34051846-C4F10434-3345-44A3-BC0B-456AC3DD304BQ34159981-95D2BC81-1E39-4751-B4CA-E853C4D64D16Q34587404-9C7D8F20-5BDD-4015-BE3C-91C9ECA47581Q34716041-A32ADD42-AF6D-4547-93BF-0A14FD2E09FCQ35011426-FA2D4E5D-6F4C-4C9D-AE38-51188BDB2432Q35585231-AB548D9A-D49B-4D63-A667-2DDD75E3F654Q35672554-BC7E5230-CEF9-404A-91DA-510066523E6AQ35997735-D91CB715-6DD0-4761-9B10-FCCAD4582C9DQ36053149-5D434DF1-EA9A-4B26-9A71-4E93E51E9107Q36064461-C38E0274-DE20-4AA5-9AAF-FFD018F38629Q36064557-87B2352C-CD70-4D2C-BE82-BB8F009115FFQ36071784-7EB999C8-3D84-4FA0-AC2F-16E58E427CA3Q36315800-14910115-6B8D-44E0-9DC9-AC99463ECAF3Q36371040-602DB47C-89C2-49E7-B703-2E5C7F477E5CQ36400754-8E3C5A73-8BE6-454F-9017-E19F09896501Q36528984-1AC894B3-32A6-4BBA-9A17-B64942F3C87DQ36630332-AFC0423F-B305-4059-95FF-58E0510BD8C2Q36667922-D3A83CE8-0DB2-4668-B41C-F0B70FDFBC0AQ36802513-6BA56D44-6EF6-4C34-827B-4AF3281EDE2BQ36945362-8B6DC526-14A7-4F84-B231-A69DFFEE715CQ36996502-129E17EE-5165-4C02-AB00-E5E92C813EA8Q37128548-4A206A1D-9DC7-4ABA-9707-CF50952739F9Q37302071-4B948896-4D35-42FC-A108-E661BB642B4FQ37581439-3776A9EE-D753-47C6-96F5-5A7F139AF9B6Q37588815-F7148970-00D5-4851-8FB0-2B8EDA7F61F9Q40839144-8BA26672-F8E4-436B-AACC-3A81AA5DB7B9Q43254876-D870FE21-C910-481C-972F-8216C5AE1E52Q44758803-F6ADD809-F557-4EEE-8A9B-0FD9970CA2C8Q47968886-91A0B205-7E40-4B34-A47E-DCA2EAFD25DEQ49296005-A8A535AF-B04D-4234-B972-322D19409B01Q49979068-236A9A34-ADD4-4C85-AB59-77036BF42AC9
P2860
Influenza virus lung infection protects from respiratory syncytial virus-induced immunopathology.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
2000年學術文章
@zh
2000年學術文章
@zh-hant
name
Influenza virus lung infection ...... virus-induced immunopathology.
@ast
Influenza virus lung infection ...... virus-induced immunopathology.
@en
type
label
Influenza virus lung infection ...... virus-induced immunopathology.
@ast
Influenza virus lung infection ...... virus-induced immunopathology.
@en
prefLabel
Influenza virus lung infection ...... virus-induced immunopathology.
@ast
Influenza virus lung infection ...... virus-induced immunopathology.
@en
P2093
P2860
P356
P1476
Influenza virus lung infection ...... virus-induced immunopathology.
@en
P2093
P2860
P304
P356
10.1084/JEM.192.9.1317
P407
P577
2000-11-01T00:00:00Z